Delivery Order SPE2DB20D7059-SPE2DB25FPXP3

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,904.63 contract is for the delivery of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product, with a period of performance through March 12, 2025. The contract is not associated with a set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product, with a ceiling value of $1,922.14 and a completion date of November 29, 2023. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,802.53 firm fixed-price contract is for the delivery of the drug product JUNEL FE 1.5 MG-30 MCG TABLET 28S, with an ultimate completion date of January 15, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug product "JUNEL FE 1.5 MG-30 MCG TABLET 28S". The contract has a ceiling value of $1,388.92 and an ultimate completion date of April 26, 2023. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,344.48 fixed-price delivery order contract is for the supply of 4567552938 - JUNEL FE 1.5 MG-30 MCG TABLET 28S, with a performance period extending through March 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,008.36, is for the delivery of Junel FE 1.5 mg-30 mcg tablets in 28-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,807.90, is for the supply of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2023 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The order, valued at $1,191.95, is for the supply of JUNEL FE 1.5 MG-30 MCG tablets. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations indicated. This order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,899.04 firm fixed-price contract is for the supply of the prescription drug Junel FE 1.5 mg-30 mcg tablet, which is used for contraception. The order has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product JUNEL FE 1.5MG-30 168S, with a potential value of $7,442.26 and a completion date of February 5, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPXP3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product, with a ceiling value of $5,746.44 and a period of performance through January 8, 2025.

The contract is a firm fixed price delivery order, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be a task order issued under that larger IDC contract.

Generated 5/21/25, 9:44 AM